Indian researchers develop new peptide therapy to treat eye infections
NEW DELHI: A team of researchers from Bose Institute in Kolkata has developed a peptide therapy that offers a promising, multidisciplinary approach to treating fungal keratitis -- a severe, sight-threatening infection of the cornea -- the clear front part of the eye.
The team, including researchers from the L V Prasad Eye Institute in Hyderabad, designed a 15-residue peptide, named SA-XV, derived from a larger host-defense peptide -- S100A12. This peptide, previously shown to inhibit fungal growth, has been characterised for its antifungal potency and mechanism of action.
Published in the Journal of Biological Chemistry, the researchers hailed the new therapy as an alternative to antimycotics (antifungals) with reduced side effects.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
PNE
Punjab News Express is dedicated to bringing reliable and engaging news to readers. He focuses on covering trending stories, regional updates, and important social issues while presenting information in a simple and clear way for the Punjabi audience.
